Meningitis
Patient Guidance
December 4, 2012 3:00 PM EST
Information on this site
is focused on the outbreak of fungal meningitis and other
infections linked to the use of injectable steroids fromthree recalled lotsof
preservative-free methylprednisolone acetate (MPA) distributed by
the New England Compounding Center (NECC).
For information on other recalls from NECC, see http://wwwdev.cdc.gov/medicationsafety/recalls/necc/.
Below are links to information for patients.
- Frequently Asked Questions For Patients: Multistate Meningitis Outbreak Investigation
- Frequently Asked Questions For Patients - Español (Spanish)
- What Should Patients Do?
Resources and Links
- Frequently Asked Questions for Patients
- CDC Digital Press Kit with Laboratory Photos and Footage
- CDC Fungal Diseases
- CDC Fungal Meningitis
- CDC Information About Additional Medical Products (non-MPA) From New England Compounding Center
- CDC Information About Voluntary Recall of All Ameridose Medical Products
U.S. Food and Drug Administration (FDA)
- FDA Statement on Fungal Meningitis Outbreak
- Questions and Answers on Fungal Meningitis Outbreak
- List of Recalled Products Related to Fungal Meningitis Outbreak
- Alert – New England Compounding Center Product Recall Information (Commonwealth of Massachusetts)
Also See: Clinician Guidance
- More: Meningitis
- Multistate Fungal Meningitis Outbreak Investigation
- Outbreak: Current Situation
- Outbreak: Current Case Count
- Outbreak: Healthcare Facilities
- Outbreak: Patient Guidance
- Outbreak: Clinician Guidance
